DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that abstracts highlighting clinical and pre-clinical data from its Viaskin technology platform were accepted for poster presentation at the 2019 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting; Food Allergy: Advances in Prevention and Treatment in San Francisco, CA, February 22 -25, 2019. The abstracts became available on the AAAAI meeting website on February 4(th).
“It is exciting to see the AAAAI highlight food allergies as a serious unmet medical need, and we look forward to underscoring epicutaneous immunotherapy as a potentially important clinical advancement in treating these diseases,” said Dr. Hugh Sampson, Chief Scientific Officer and Interim Chief Medical Officer of DBV Technologies and Kurt Hirschhorn Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai. “Epicutaneous immunotherapy, by using the skin to activate the immune system, offers a novel way to potentially transform how we treat our food-allergic patients in a non-invasive manner.”
Selected Abstracts of Interest:
Peanut Allergy Data
“Efficacy and Safety of Epicutaneous Immunotherapy for Peanut Allergy in Subjects With and Without Atopic Dermatitis” will be presented by Dr. Carla M.
Davis, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX. * Poster Number: 735
* Session Number: 4208
* Session Title: Food Immunotherapy * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
Davis, Texas Children’s Hospital and Baylor College of Medicine, Houston, TX. * Poster Number: 735
* Session Number: 4208
* Session Title: Food Immunotherapy * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
“Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in Young Children” will be presented by Dr. David Fleischer, Director, Allergy and Immunology Center and Associate Section Head, Children’s Hospital Colorado * Poster Number: 749
* Session Number: 4208
* Session Title: Food Immunotherapy * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
* Session Number: 4208
* Session Title: Food Immunotherapy * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
EPIT Mechanism of Action Research
“Skin Dendritic Cells Progressively Subvert The Activation Of Pathogenic Type-2 Immunity Upon Epicutaneous Allergen Immunotherapy” will be presented by Dr. LeoLaoubi, DBV Technologies.
* Poster Number: 734
* Session Number: 4208
* Session Title: Food Immunotherapy * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
* Poster Number: 734
* Session Number: 4208
* Session Title: Food Immunotherapy * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
“Langerhans Cells Increase Their Expression of Integrin avb8 Through Migration and are Needed for Tregs Induction by Epicutaneous Immunotherapy (EPIT)” will be presented by Dr. Vincent Dioszeghy, DBV Technologies.
* Poster Number: 622
* Session Number: 3802
* Session Title: BCI Featured Poster Session * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Sunday February 24, 2019 * Presentation Time: 4:30 – 6:00pm
* Poster Number: 622
* Session Number: 3802
* Session Title: BCI Featured Poster Session * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Sunday February 24, 2019 * Presentation Time: 4:30 – 6:00pm
Cashew Nut Allergy Data
“Development of a Cashew Nut Allergy Mouse Model to Evaluate the Efficacy of Epicutaneous Desensitization Treatment” will be presented by Dr. Pierre-Louis Hervé, DBV Technologies.
* Poster Number: 787
* Session Number: 4209
* Session Title: Food Allergy and Treatment * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
* Poster Number: 787
* Session Number: 4209
* Session Title: Food Allergy and Treatment * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
DBV-Sponsored Research
“Shared Cooking Equipment in Restaurants: A Quantitative Risk Assessment for Peanut-Allergic Consumers” will be presented by Dr. Benjamin C. Remington, TNO Ziest, The Netherlands.
* Poster Number: 724
* Session Number: 4207
* Session Title: Food Allergen Structures * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
* Poster Number: 724
* Session Number: 4207
* Session Title: Food Allergen Structures * Poster Hall Location: Moscone Center South, Exhibition Level, Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45am-10:45am
“Double-Blind, Placebo-Controlled Randomized Trial of Epicutaneous Immunotherapy in Children with Milk-Induced Eosinophilic Esophagitis” will be presented by Dr.
Jonathan Spergel, Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.
* Poster Number: L30
* Session Number: 4216
* Session Title: Late Breaking Poster Session * Poster Hall Location: Moscone Center South Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45-10:45am
Jonathan Spergel, Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.
* Poster Number: L30
* Session Number: 4216
* Session Title: Late Breaking Poster Session * Poster Hall Location: Moscone Center South Hall B * Presentation Date: Monday, February 25, 2019 * Presentation Time: 9:45-10:45am
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.